glp 1 and sarcopenia in the Era of GLP-1 Medications Glucagon-like peptide-1 receptor agonists and
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 32.Monti G., Gomes Moreira D., Richner M., Mutsaers H.A.M., Ferreira N., Jan A

The most common ones are reduced appetite, trouble sleeping, dry mouth, headache, and a sense of feeling more activated than usual

Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP

Clinicians should emphasize that GLP-1 medications complement but do not replace evidence-based lipid management with statins
Annexin V-FITC apoptosis detection kit, CCK-8, Calcein/PI cell viability/cytotoxicity, ROS and TUNEL assay kits were purchased from Beyotime Biotechnology
